Mr. Jagdip Bal reports

UMBRAL ACMPR APPLICATION UPDATE

Umbral Energy Corp.'s PhyeinMed Inc. is in communication with Health Canada and its ACMPR (access to cannabis for medical purposes regulations) application and has been assured that the application is progressing through the application process.

PhyeinMed's president and chief executive officer, Debra Senger, stated: "We have been satisfied with the progress of the application these last few months. Health Canada is finalizing the final vetting process from the information they receive from various government departments responsible for security clearances with respect to PhyeinMed's corporate personnel and persons in charge of the application. Although the time restraints involved with the application have been lengthy, we have been able to continue with the process and maintain confidence with our partners and key persons involved in the application. We look forward to progressing to the final review stage and await the approvals necessary to receive a prepare for inspection notification from Health Canada. Once received, PhyeinMed plans to proceed with the acquisition of its facility and prepare for inspection."

The Liberal government has emphasized its desire to legalize, regulate and restrict access to cannabis and the move toward legalization in 2017 is likely to start with government-vetted licensed producers as suppliers. Estimates in the Canadian cannabis space could reach $3-billion in annual sales in 2024, with an even larger recreational market of $3-billion to $5-billion that same year, for a combined total of $6-billion to $8-billion, with further upside coming from increased tourism and international expansion or trade.

Based on a recent published report, 1,749,790 square metres of indoor grow space will be required to supply the Canadian recreational market or over 290 CFL (Canadian Football League) football fields. PhyeinMed's total potential new grow area with expansion could be 420,000 square feet of grow space using an additional seven acres of the land included in the current proposed property acquisition.

The management of PhyeinMed has been nurturing potential partnerships, international export and import partners, strategic alliances, accessory and ancillary relationships, and revenue-generating opportunities during the course of the application process. Short-term and long-term goals for creating revenue have been identified and the company plans to investigate and pursue these opportunities moving forward with Umbral as an investment partner.

About Umbral Energy

The company is currently listed as a junior resource issuer having mineral exploration projects.

The company has mineral exploration projects in Utah, Nevada and Quebec. In addition, the company has an interest in PhyeinMed, which has applied for a licence from Health Canada to legally grow and sell medical marijuana.

We seek Safe Harbor.